BioCardia to Participate in a Fireside Chat at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
SUNNYVALE, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, will participate virtually in a fireside chat at A.G.P.'s Healthcare Company Showcase.
Fireside Chat Details:
- Time: 11:40 AM ET
- Date: Wednesday, May 20, 2026
Investors can register for the conference and view the fireside chat here.
About BioCardia®
BioCardia, Inc., headquartered in Sunnyvale, California, is developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease. CardiAMP® autologous and CardiALLO™ allogeneic cell therapies are the Company’s biotherapeutic platforms for the treatment of heart disease. These therapies are enabled by its Helix™ biotherapeutic delivery and Morph® vascular navigation product platforms. For more information visit: www.BioCardia.com.
CONTACT: Media Contact: Miranda Peto, Investor Relations Email: mpeto@BioCardia.com Phone: 650-226-0120 Investor Contact: David McClung, Chief Financial Officer Email: investors@BioCardia.com Phone: 650-226-0120
Mentioned In This Article
Latest News
| Nov-12 | |
| Nov-12 | |
| Nov-10 | |
| Nov-09 | |
| Nov-06 | |
| Oct-19 | |
| Oct-07 | |
| Oct-01 | |
| Sep-23 | |
| Sep-10 | |
| Aug-24 | |
| Aug-13 | |
| Aug-12 | |
| Aug-05 | |
| Jun-18 |
